Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms

Journal of Pineal Research

Volumn 54, Issue 1, 2013, Pages 58-68

  Das, Arabinda ^a   Wallace IV, Gerald ^a   Reiter, Russel J ^b   Varma, Abhay K ^a   Ray, Swapan K ^c   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Calbindin D28K; Calpain; G protein receptor 50; Glutamate toxicity; Melatonin receptors; Parvalbumin; Ventral spinal cord 4.1

Indexed keywords

ANGIOGENIC FACTOR; CALBINDIN; CALCIUM BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUTAMIC ACID; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR; ORPHAN G PROTEIN RECEPTOR 50; PARVALBUMIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EXCITOTOXICITY; HUMAN; HUMAN CELL; NEUROPROTECTION; PROTEIN EXPRESSION; RNA INTERFERENCE; SPINAL CORD MOTONEURON; UPREGULATION;

APOPTOSIS; CALBINDIN D28K; CALPAIN; G-PROTEIN RECEPTOR 50; GLUTAMATE TOXICITY; MELATONIN RECEPTORS; PARVALBUMIN; VENTRAL SPINAL CORD 4.1;

ANIMALS; APOPTOSIS; CALBINDINS; CELL LINE; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; GLUTAMIC ACID; MICE; MOTOR NEURONS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PARVALBUMINS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MELATONIN; RNA, SMALL INTERFERING;

EID: 84872680691     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2012.01022.x     Document Type: Article

References (37)

1. LEPORE AC. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury. J Vis Exp 2011; 18:55.
2. DONG XX, WANG Y, QIN ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 2009; 30:379-387.
3. CACCAMO D, CAMPISI A, CURRÒ M. Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases. Amino Acids 2004; 27:373-379.
4. KWON KJ, KIM JN, KIM MK et al. Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection. J Pineal Res 2011; 50:110-123.
5. TSAI MC, CHEN WJ, TSAI MS et al. Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats. J Pineal Res 2011; 51:233-245.
6. ROSALES-CORRAL SA, ACUÑA-CASTROVIEJO D, COTO-MONTES A et al. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 2012; 52:167-202.
7. BONNEFONT-ROUSSELOT D, COLLIN F, JORE D, GARDÈS-ALBERT M. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50:328-335.
8. WU UI, MAI FD, SHEU JN et al. Melatonin inhibits microglial activation, reduces pro-inflammatory cytokine levels, and rescues hippocampal neurons of adult rats with acute Klebsiella pneumoniae meningitis. J Pineal Res 2011; 50:159-170.
9. HAN F, CHEN YX, LU YM et al. Regulation of the ischemia-induced autophagy-lysosome processes by nitrosative stress in endothelial cells. J Pineal Res 2011; 51:124-135.
10. GALANO A, TAN DX, REITER RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51:1-16.
11. POEGGELER B, SAARELA S, REITER RJ, MANCHESTER LC, BARLOW-WALDEN LR. Melatonin - a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 1994; 738:419-420.
12. REITER RJ, PAREDES SD, MANCHESTER LC, TAN DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44:175-200.
13. NATARAJAN M, SADEGHI K, REITER RJ et al. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-KappaB. Biochem Mol Biol Int 1995; 37:1063-1070.
14. SAMANTARAY S, DAS A, THAKORE NP et al. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47:134-142.
15. GODSON C, REPPERT SM. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997; 138:397-404.
16. DUBOCOVICH ML, MARKOWSKA M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27:101-110.
17. LEVOYE A, DAM J, AYOUB MA et al. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J 2006; 25:3012-3023.
18. 2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 2006; 40:332-342.
19. HARDELAND R. Melatonin: signaling mechanisms of a pleiotropic agent. BioFactors 2009; 35:183-192.
20. JOCKERS R, MAURICE P, BOUTIN JA, DELAGRANGE P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol 2008; 154:1182-1195.
21. BAIMBRIDGE KG, CELIO MR, ROGERS JH. Calcium-binding proteins in the nervous system. Trends Neurosci 1992; 15:303-308.
22. GOODMAN JH, WASTERLAIN CG, MASSARWEH WF et al. Calbindin-D28k immunoreactivity and selective vulnerability to ischemia in the dentate gyrus of the developing rat. Brain Res 1993; 606:309-314.
23. MATTSON MP, RYCHLIK B, CHU C, CHRISTAKOS S. Evidence for calcium reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 1991; 6:41-51.
24. MATTSON MP, CHENG B, BALDWIN SA et al. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J Neurosci Res 1995; 42:357-370.
25. DAS A, BELAGODU A, REITER RJ et al. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008; 45: 117-124.
26. DAS A, MCDOWELL M, PAVA MJ et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169.
27. ELLIOTT JL, SNIDER WD. Parvalbumin is a marker of ALS-resistant motor neurons. NeuroReport 1995; 6:449-452.
28. DEKKERS J, BAYLEY P, DICK JR et al. Over-expression of parvalbumin in transgenic mice rescues motoneurons from injury-induced cell death. Neuroscience 2004; 123:459-466.
29. YENARI MA, MINAMI M, SUN GH et al. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 2001; 32:1028-1035.
30. BALÍK A, KRETSCHMANNOVÁ K, MAZNA P et al. Melatonin action in neonatal gonadotrophs. Physiol Res 2004; 53(Suppl 1):S153-S166.
31. DEL RÍO B, GARCÍA PEDRERO JM, MARTÍNEZ-CAMPA C et al. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem 2004; 279:38294-38302.
32. LEE GS, CHOI KC, HAN HJ, JEUNG EB. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Mol Cell Endocrinol 2007; 15:277.
33. CARRILLO-VICO A, REITER RJ, LARDONE PJ et al. The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 2006; 7:423-431.
34. CARRILLO-VICO A, LARDONE PJ, FERNANDEZ-SANTOS JM et al. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J Clin Endocrinol Metab 2005; 90:992-1000.
35. ZENG KW, WANG XM, KO H et al. Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid β-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway. Eur J Pharmacol 2011; 672:45-55.
36. KILIC U, KILIC E, REITER RJ, BASSETTI CL, HERMANN DM. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 2005; 38:67-71.
37. KILIC U, YILMAZ B, UGUR M et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012; 52:228-235.